Security
HORIZON SPACE ACQUISITION I CORP USD RED WTS 12/27/2029 (Cayman Islands) · HSPWF
HSPWFOTCWarrantCurrentCIK 1946021Updated Oct 14, 2026
HSPWF price & chart
Loading TradingView…
OTC:HSPWF on TradingView ↗About the company
Horizon Space Acquisition I Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
In the news
No coverage from other publishers is available.
SEC disclosures
Recent filings
425 filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
10-Q filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 23,120,114Source | 62,252,189Source | 964,521Source | 22,550,478Source | 61,210,296Source | 1,227,023Source | 22,019,402Source | 60,317,669Source | 1,230,570Source | 21,327,906Source | 68,245,763Source | 70,926,038Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 561,406Source |
| Assets, CurrentUSD | 28,929Source | 148,420Source | 210,851Source | 55,759Source | 82,265Source | 36,657Source | 114,559Source | 153,859Source | 50,579Source | 7,815Source | 298,908Source | 685,471Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 5,892,658Source | 4,040,244Source | 6,488,228Source | 5,472,050Source | 3,294,743Source | 6,215,974Source | 5,016,861Source | 3,031,328Source | 6,095,957Source | 4,396,819Source | 2,828,718Source | 2,449,842Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source | 231Source |
| Additional Paid in CapitalUSD | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -5,863,960Source | -3,892,055Source | -6,277,608Source | -5,416,522Source | -3,212,709Source | -6,179,548Source | -4,902,533Source | -2,877,700Source | -6,045,609Source | -4,389,235Source | -2,530,041Source | -1,744,886Source |
| Stockholders' Equity Attributable to ParentUSD | -5,863,729Source | -3,891,824Source | -6,277,377Source | -5,416,291Source | -3,212,478Source | -6,179,317Source | -4,902,302Source | -2,877,469Source | -6,045,378Source | -4,389,004Source | -2,529,810Source | -1,744,655Source |
| Liabilities and EquityUSD | 23,120,114Source | 62,252,189Source | 964,521Source | 22,550,478Source | 61,210,296Source | 1,227,023Source | 22,019,402Source | 60,317,669Source | 1,230,570Source | 21,327,906Source | 68,245,763Source | 70,926,038Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,477,658Source | 1,625,244Source | 4,073,228Source | 3,057,050Source | 879,743Source | 3,800,974Source | 2,601,861Source | 616,328Source | 3,680,957Source | 1,981,819Source | 413,718Source | 34,842Source |
| Additional Financial Items | ||||||||||||
| Partners' CapitalUSD | — | — | — | — | — | — | — | — | — | 700,000Source | — | — |
| Preferred Stock, Value, Issued | — | —Source | — | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 149,028Source | 296,392Source | — | 75,887Source | — | 71,454Source | — | 2,112,351Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -169,917Source | -207,007Source | -585,924Source | -975,466Source | -378,125Source | — |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 0Source | -360,000Source | 20,920,092Source | 49,798,309Source | 5,745,184Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 160,000Source | 610,000Source | -20,306,089Source | -49,098,309Source | -5,645,184Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 7,679Source | 128,169Source | 204,176Source | 13,259Source | 25,977Source | 50,808Source | 35,894Source | 7,815Source | 283,281Source | 561,406Source |
| Additional Financial Items | ||||||||||||
| Net Income (Loss) Attributable to ParentUSD | — | — | 149,028Source | 296,392Source | -90,586Source | 75,887Source | -123,564Source | 71,454Source | 203,618Source | 2,112,351Source | 2,911,033Source | — |
| Operating Costs and ExpensesUSD | — | — | 87,438Source | 499,346Source | 98,060Source | 153,989Source | 133,939Source | 153,298Source | 576,374Source | 1,059,194Source | 560,155Source | — |
| Other Interest and Dividend IncomeUSD | — | — | — | 795,738Source | 7,474Source | 229,876Source | 10,375Source | 224,752Source | 779,992Source | 3,171,545Source | 3,471,188Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | —Source | —Source | — | —Source | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -87,438Source | -499,346Source | -98,060Source | -153,989Source | -133,939Source | -153,298Source | -576,374Source | -1,059,194Source | -560,155Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 149,028Source | 296,392Source | -90,586Source | 75,887Source | -123,564Source | 71,454Source | 203,618Source | 2,112,351Source | 2,911,033Source |
| Additional Financial Items | |||||||||||
| Operating Costs and ExpensesUSD | — | — | 87,438Source | 499,346Source | 98,060Source | 153,989Source | 133,939Source | 153,298Source | 576,374Source | 1,059,194Source | 560,155Source |
| Other Cost and Expense, OperatingUSD | — | — | 87,438Source | 249,346Source | 98,060Source | 113,989Source | 133,939Source | 118,298Source | 471,374Source | 661,031Source | 560,155Source |
| Other Interest and Dividend IncomeUSD | — | — | — | 795,738Source | 7,474Source | 229,876Source | 10,375Source | 224,752Source | 779,992Source | 3,171,545Source | 3,471,188Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | —Source | —Source | — | —Source | — | —Source | — | — | — |
| Net Investment Income | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — |
Filing attachments
hspo_ex991.htm · 425 · 2026-10-13
EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Definitive Business Combination Agreement with ArcheNova Biotech Corp. NEW YORK, NY, October 13, 2026 (Accesswire) - Horizon Space Acquisition I Corp. (“HSPO”) (OTC: HSPOF), a publicly traded special purpose acquisition company, and ArcheNova Biotech Corp. (“ArcheNova” or the “Company”), a clinical-stage, platform-based biopharmaceutical company, focusing on the research, development, clinical translation, scalable manufacturing and glo…
Read attachment ↗hspo_ex991.htm · 8-K · 2026-10-13
EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Definitive Business Combination Agreement with ArcheNova Biotech Corp. NEW YORK, NY, October 13, 2026 (Accesswire) - Horizon Space Acquisition I Corp. (“HSPO”) (OTC: HSPOF), a publicly traded special purpose acquisition company, and ArcheNova Biotech Corp. (“ArcheNova” or the “Company”), a clinical-stage, platform-based biopharmaceutical company, focusing on the research, development, clinical translation, scalable manufacturing and glo…
Read attachment ↗hspo_ex991.htm · 8-K · 2025-12-11
EX-99.1 2 hspo_ex991.htm PRESS RELEASE hspo_ex991.htm EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Voluntary Delisting from Nasdaq Capital Market New York, December 3, 2025 -- Horizon Space Acquisition I Corp. (Nasdaq: HSPO, HSPOU, HSPOW, HSPOR) (the “Company,” “we” or “our”), a special purpose acquisition company, today notified the Nasdaq Stock Market LLC (“Nasdaq”) of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasd…
Read attachment ↗hspo_ex992.htm · 8-K · 2025-12-11
EX-99.2 3 hspo_ex992.htm PRESS RELEASE hspo_ex992.htm EXHIBIT 99.2 Horizon Space Acquisition I Corp. Announces Effective Date of Nasdaq Delisting and Commencement of OTC Trading New York, December 10, 2025 -- Horizon Space Acquisition I Corp. (Nasdaq: HSPO, HSPOU, HSPOW, HSPOR) (the “Company”), a special purpose acquisition company, today announces that its ordinary shares, units, warrants, and rights will be suspended from trading on the Nasdaq Capital Market (“Nasdaq”) prior to market o…
Read attachment ↗